glp-1 mcas What does emerging evidence say about medications and mast cell activation — and why are some clinicians seeing surprising benefits in patients who aren't taking them for weight loss? On last As a clinician who treats

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial

FIGURE 8 PCs and their metabolites exhibit significant therapeutic potential in the pathogenesis of diabetic nephropathy through multiple mechanisms, including antioxidant and anti-fibrotic effects, as well as the regulation of key signaling pathways

Newer delivery methods are also changing the cost conversation

10.1038/ncomms12840 62 OdaT.YangY.UchinoumiH.ThomasD

Neural indicators of food cue reactivity, regulation, and valuation and their associations with body composition and daily eating behavior